StockData
BioLineRx Ltd. logo

BioLineRx Ltd. (BLRX) income statement

BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$0.96−0.10 (-9.07%)

Close on Nov 20, 2026Market cap $4.19MP/E –Yield –

See a number that looks wrong?